Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Hindustan Unilever (HUL)- the country's leading FMCG player will come up with its Q2 earnings on October 23, 2024 (Wednesday) ...

Acrocallosal Syndrome Therapeutics MarketThe global Acrocallosal Therapeutics Market is currently valued at USD 147.9 million ...

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

The rising cost of living continues to hit Nigerian households and the latest example is the price of toothpaste, which is ...

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

Earnings before interest, tax, depreciation, and amortisation (Ebitda) is likely to remain flat at Rs 3,698.7 crore on an ...

He then served as CEO of Reliant Pharmaceuticals, helping lead the company to its acquisition by GlaxoSmithKline in 2007. He ...